Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2010
12/22/2010EP1368013B1 Cyclohexenone derivative for treating diabetic neuropathy
12/22/2010EP1135496B1 Ucp5
12/22/2010EP1019077B2 Novel exendin agonist compounds
12/22/2010CN1973681B Technological process of producing oat diet fiber and nutritious powder with oat bran
12/22/2010CN1812973B Indazole compounds useful as protein kinase inhibitors
12/22/2010CN1802366B C-glycoside derivatives and salts thereof
12/22/2010CN1729158B Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
12/22/2010CN1547477B Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
12/22/2010CN101925610A Non-hydrolyzable nucleoside di- or tri-phosphate derivatives and uses thereof
12/22/2010CN101925603A Modulators of cystic fibrosis transmembrane conductance regulator
12/22/2010CN101925586A Novel heterocyclic compounds
12/22/2010CN101925353A VEGFC production promoter
12/22/2010CN101925307A High energy liquid enteral nutritional composition
12/22/2010CN101921810A Method for preparing xylitol and L-arabinose mixed crystal from xylose mother liquid
12/22/2010CN101921772A Human antibodies that bind human IL-12 and methods for producing
12/22/2010CN101921332A Recombinant human insulin and production method thereof
12/22/2010CN101921309A L-cystyl-2-L-aspartic tripeptide and derivatives, preparation method and application thereof
12/22/2010CN101921270A Mangiferin berberine salt, preparation method thereof and use thereof
12/22/2010CN101921267A Beta -lactamyl vasopressin Vla antagonists
12/22/2010CN101921182A Method for extracting and purifying 5-O-methyl-myo-inositol in plants
12/22/2010CN101920019A Hydrophilic polymer-puerarin specific conjugated non-hemolytic conjugate
12/22/2010CN101920004A Preparation and application of coconut globulin ferrous complex iron supplement agent
12/22/2010CN101920003A Traditional Chinese medicine composite for reducing fat and losing weight and preparation method thereof
12/22/2010CN101919999A Tea-ginger-vinegar medicament
12/22/2010CN101919972A Internal motion medicine
12/22/2010CN101919965A Drug for treating hyperlipidaemia
12/22/2010CN101919945A Medicine for treating obesity
12/22/2010CN101919943A Medicament for preventing or treating cardiovascular and cerebrovascular diseases
12/22/2010CN101919937A Tea plaster
12/22/2010CN101919923A Coffee capsules
12/22/2010CN101919917A Chinese patent medicament of cardio-cerebral nephritis-health pills
12/22/2010CN101919906A Novel application of salvianolic acid compound as water-soluble component in salvia miltiorrhiza extract
12/22/2010CN101919901A Application of total aglycone of gleditsia sinensis and echinocystic acid in preparation of alpha-glucosidase inhibitor drugs
12/22/2010CN101919900A Fructose-contained astragalus oral liquid
12/22/2010CN101919882A Application of red yeast rice to preparing abdominal aneurvsm medicine
12/22/2010CN101919866A Drug composition of complex fat-soluble vitamins and preparation method thereof
12/22/2010CN101919851A Medicinal composition for treating type 2 diabetes of mammalian and human
12/22/2010CN101919844A Compound for controlling autoimmune disease and use thereof
12/22/2010CN101919839A Usage of mangiferin calcium salt taken as AMPK agonist
12/22/2010CN101919835A Application of 2-acetylamino gentisic acid to preparing insulin sensitizer
12/22/2010CN101919831A Pharmaceutical composition compounded with compound liposoluble vitamins and preparation method thereof
12/22/2010CN101919830A Novel application of 2,4-dimethoxyl trans-stilben
12/22/2010CN101919800A Orodispersible pharmaceutical composition for oral, oromucosal or sublingual administration of agomelatine
12/22/2010CN101919584A Slimming functional electronic cigarette liquid
12/22/2010CN101919368A Preparation of hirudinaria manillensis and novel application thereof in Chinese medical science blood stasis
12/22/2010CN101530592B Traditional Chinese medicine for treating diabetic gastroparesis
12/22/2010CN101418000B DPP-IV inhibitor derivates containing benzofuran sulfonyl ureas
12/22/2010CN101371925B Nano silver-cell growth factor sustained-release composite body as well as preparation method and use thereof
12/22/2010CN101361768B Diabetes treating medicine
12/22/2010CN101336965B Chinese prepared medicine for improving sugar tolerance and reducing blood sugar and preparation method thereof
12/22/2010CN101288705B Medicine composition mainly for adjusting blood fat and its preparation method
12/22/2010CN101244121B Leonurus heterophyllus total alkaloid extract and preparation thereof
12/22/2010CN101181373B Cortex moutan valid target pharmaceutical combination, preparation method and application thereof
12/22/2010CN101167776B Chicory seed effective part and preparation method and application thereof
12/22/2010CN101103755B Method for producing convenient nutritive rice-tea and product
12/22/2010CN101057908B Heart and brain health dispersion tablet and its preparation method
12/22/2010CN101049348B Chinese traditional medicine for treating hyperlipemia, and preparation method
12/22/2010CN101040884B Method for controlling the quality of Chinese traditional medicine araloside
12/22/2010CN101040650B Health-care type ganoderma lucidum combined tea
12/22/2010CN101001836B Pyrrolidin-2-one and piperidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
12/21/2010US7855294 (6R,8S)-6-(spiro[isobenzofuran-1-(3H), 4'-piperidin]-1'-ylmethyl)-5,6,7,8-tetrahydroquinolin-8-ol), exhibiting an antagonism to binding of nociceptin to opioid receptor-like-1 receptors, useful as medicines for diseases associated with pain and appetite control or memory and learning
12/21/2010US7855277 antibody or antiserum directed against a structural protein of Ljungan picornavirus; cardiovascular, nervous system and metabolic disorders; Myocarditis, Cardiomyopathia, Guillain Barre Syndrome, and Diabetes Mellitus, Multiple Sclerosis, Chronic Fatigue Syndrome, Myasthenia Gravis
12/21/2010US7855219 2-Amino-4-(1,3-benzodioxol-5-yl)-6-benzyloxy-3,5-pyridinedicarbonitrile, acting as adenosine-receptor-selective ligands, for the prophylaxis and/or treatment of cardiovascular disorders
12/21/2010US7855203 Indazolyl-substituted pyrroline compounds as kinase inhibitors
12/21/2010CA2569654C Benzimidazolone carboxylic acid derivatives
12/21/2010CA2503117C Substituted 4-alkoxyoxazol derivatives as ppar agonists
12/21/2010CA2483345C Imidazolinylmethyl aralkylsulfonamides
12/21/2010CA2470109C Substituted phenyl naphthalenes as estrogenic agents
12/21/2010CA2468374C Glp-1 derivatives
12/21/2010CA2464130C Mch antagonists for the treatment of obesity
12/21/2010CA2426654C 2,4,8-trisubstituted-8h-pyrido[2,3-d}pyrimidin-7-one compounds
12/21/2010CA2412004C Glucagon-like peptide-1 analogs
12/21/2010CA2397981C Azacyclic compounds for use in the treatment of serotonin related diseases
12/21/2010CA2329138C Glycoproteins having lipid mobilising properties and therapeutic applications thereof
12/16/2010WO2010144821A1 Glycomacropeptide medical foods for nutritional management of phenylketonuria and other metabolic disorders
12/16/2010WO2010144785A2 Diketopiperazine microparticles with defined isomer contents
12/16/2010WO2010144664A1 Thiophenes as glucagon receptor antagonists, compositions, and methods for their use
12/16/2010WO2010144571A1 Histamine h3 inverse agonists and antagonists and methods of use thereof
12/16/2010WO2010144502A2 Growth hormone polypeptides and methods of making and using same
12/16/2010WO2010144452A1 Methods for increasing thermogenic adipocytes
12/16/2010WO2010144140A2 Egfr and par2 regulation of intestinal permeability
12/16/2010WO2010144038A1 Melanocortin receptor-specific peptides
12/16/2010WO2010143977A1 Copepod oil composition, formulations comprising the oil composition, and the use thereof to reduce accumulation of visceral fat, improve glucose tolerance, and prevent or treat obesity related diseases and disorders
12/16/2010WO2010143947A1 Nutrition for improving muscle strength in elderly
12/16/2010WO2010143733A1 Novel fused cyclic compound and use thereof
12/16/2010WO2010143719A1 Alkaline decomposition product of hop extract and use thereof
12/16/2010WO2010143065A1 Compositions and methods for increasing lifespan and health span
12/16/2010WO2010143061A1 Composition used to prevent and treat red blood cell coagulation
12/16/2010WO2010143053A1 Methods and compositions for treating insulin resistance, diabetes mellitus type 2, metabolic syndrome and related disorders
12/16/2010WO2010142665A1 Glp-1 and fgf21 combinations for treatment of diabetes type 2
12/16/2010WO2010142650A1 Novel cyclopentane derivatives
12/16/2010WO2010142296A1 Sorcs1-like agent for use in the treatment of insulin resistance and diseases related thereto
12/16/2010WO2010142258A1 Production and use of antitumoral, antibiotic and insecticidal cyclodepsipeptides
12/16/2010WO2010142183A1 Pharmaceutical composition for treatment of type 2 diabetes in mammals including human beings
12/16/2010WO2010142182A1 Pharmaceutical composition for treatment of type 2 diabetes in mammals including human beings
12/16/2010WO2010093784A3 Modified virus vectors and methods of making and using the same
12/16/2010WO2010086867A3 Peptides, pharmaceutical compositions comprising same and uses thereof
12/16/2010WO2009144555A8 Pyrazolospiroketone acetyl-coa carboxylase inhibitors
12/16/2010US20100319073 GDE Compositions and Methods
12/16/2010US20100318060 Injection Device With Rotatable Dose Setting
1 ... 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 ... 1298